Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Enrolling by invitation × Lymphedema × Clear all

Phase

Phase NA 2 Phase 2/3 1

Status

Enrolling by invitation 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Lymphedema 1 Leukemia, Promyelocytic, Acute 1 Cholangiocarcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06306274 2024-12-02

Topical Tacrolimus for Breast Cancer-related Lymphedema

Odense University Hospital

Phase 2/3 Enrolling by invitation

Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡